Leaps by Bayer Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
14

- Investments
-
112
- Portfolio
-
59
- Exits
-
21

Leaps by Bayer General Information
Description
Founded in 2015, Leaps by Bayer is the corporate venture capital arm of Bayer and is based in Leverkusen, Germany. The firm prefers to invest in the healthcare, agriculture, and life sciences sectors.
Contact Information
Investor Status
Actively Seeking New Investments
Primary Investor Type
Corporate Venture Capital
Other Investor Types
Impact Investing
Primary Office
- Kaiser-Wilhelm-Allee 1
- 51373 Leverkusen
- Germany
+49 0214 000
Leaps by Bayer Investments (112)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
ReCode Therapeutics | 19-Sep-2023 | Later Stage VC | 00000 | Drug Delivery | Generating Revenue | 0ü0000 00000000 00 |
0000 | 09-Jun-2023 | 00000 00000 | Other Healthcare Technology Systems | Generating Revenue | ||
000000 00000000000 | 31-May-2023 | 00000 00000 | 0000 | Drug Discovery | Generating Revenue | 00000 0000000 00.0 |
000000000 000 | 16-May-2023 | 00000 00000 | 00000 | Drug Discovery | Clinical Trials - Phase 2 | 00000 00000 00.0 |
0000000000 | 08-May-2023 | 00000 00000 | 000.00 | Electronic Equipment and Instruments | Generating Revenue | 0000 0000000 |
00000000000 | 21-Mar-2023 | 00000 00000 | 000.00 | Business/Productivity Software | Generating Revenue | 0000 0000000 |
00000 (00000000000 | 16-Mar-2023 | 00000 00000 | 0000 | Other Agriculture | Generating Revenue | 00000 000000 00.0 |
0000000 00000000 | 27-Feb-2023 | 00000 00000 | 00000 | Biotechnology | Startup | 00000 0000000 00.0 |
Curie.Bio | 14-Feb-2023 | Early Stage VC | 00000 | Other Financial Services | Generating Revenue | |
Metagenomi | 05-Jan-2023 | Later Stage VC | 00000 | Drug Discovery | Pre-Clinical Trials | 0ü0000 00000000 00 |
Leaps by Bayer Exits (21)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Azitra | 15-Jun-2023 | IPO | 00.00 |
0000000 (00000 000 | 23-Jan-2023 | 000000000000000000 | |
0000 000 | 18-Oct-2022 | 000000000000000000 | |
0000000000 | 01-Aug-2022 | 000000000000000000 | |
00000 000 | 08-Jun-2022 | 0000000 000000 | 00000 |
00000 00000000 | 24-Feb-2022 | 000000000000000000 | |
00000 00000000 | 08-Oct-2021 | 000 | 00000 |
0000000 0000000000 | 18-Jun-2021 | 000 | 00000 |
Recursion Pharmaceuticals | 16-Apr-2021 | IPO | 00000 |
BlueRock Therapeutics | 20-Sep-2019 | Merger/Acquisition | 00000 |
Leaps by Bayer Investments by Industry, Year, and Region
Leaps by Bayer Team (16)
Name | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
Denise Boehme | Director of Portfolio Strategy & Reporting | Leverkusen, Germany | |||
Peisze Ng | Director of Venture Investments | Leverkusen, Germany | |||
Sara Olson Ph.D | Director Venture Investments Agriculture | Boston, MA | |||
Alev Oezmen | Executive, Portfolio Strategy & Reporting Support | Leverkusen, Germany | |||
Jürgen Eckhardt MD | Executive Vice President & Head | 00 | 0 | Leverkusen, Germany |
Leaps by Bayer Co-Investors (411)
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
Alexandria Venture Investments | 10 | 0 | 0 |
![]() |
![]() |
ARCH Venture Partners | 0 | 0 |
![]() |
![]() |
|
RA Capital Management | 0 | 0 |
![]() |
![]() |
|
Catalio Capital Management | 0 | 0 |
![]() |
![]() |
|
Polaris Partners | 0 | 0 |
![]() |
![]() |